Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Strategies for larger families focus on prioritization and flexible allocations. Learn how to tailor a zero-based plan to multiple dependents.
27,842 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...
Amazon’s chip initiative is quietly redefining cloud economics. This article breaks down the numbers, the tech stack,...
Two Vanguard growth options vie for dominance in a shifting market. This guide breaks down vanguard growth growth etf...
A fund just opened million in Trustmark shares signals conviction, but it isn’t a guaranteed win. This guide explains...
Curious about a strategy that blends stock ownership with option income? This deep-dive on the JPMorgan Equity Premiu...
SoftBank dismisses Elon Musk’s orbital data center idea, choosing immediate Earth-based expansion. The move comes as ...
SpaceX is exploring bold ways to run data centers in orbit, powered by solar energy. For NuScale Power investors, the...
Alphabet surged more than 70% over the past year, but the question remains: is it too late to buy? This guide looks a...
ai healthcare news is accelerating how we diagnose, treat, and manage care. This guide breaks down the trends, how to...
IP Strategy said its board approved a buyback of up to 1,000,000 common shares through Dec. 31, 2026, potentially tri...
A major fund trimmed Freshworks stock by hundreds of thousands of shares, triggering a 60% year-long drop in the stoc...